Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q3 2023 Ophthalmology Update

Skip to the end of the Expertise Menu

Q3 2023 Ophthalmology Update

The ophthalmology sector experienced sustained deal flow in the third quarter, although at a slower pace than in previous quarters. Provident attributes the slight slowdown in deal activity to tighter lending markets and more selective M&A strategies from existing platforms. PE-backed consolidators have been more strategic in who they align with, focusing on practices in adjacent markets or with significant geographic overlap.

Provident expects transaction volumes to pick back up in Q4 and in 2024, as lending markets soften, interest rate levels stabilize, and existing PE-backed platforms prepare for transaction processes of their own.

To print and download the full Ophthalmology Services Update report, please click below…

[holo_button icon=”/wp-content/uploads/2023/10/Q3-23-Ophthalmology.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]